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In cervical cancer screening, colposcopically directed biopsy is the gold
standard method for identifying intraepithelial and occult invasive le-
sions of the uterine cervix. As biopsy needs special expertise and the
procedure is not convenient for the patients, we sought to evaluate col-
poscopically directed brush cytology as a substitute for biopsy of cervi-
cal lesions. We studied a series of 150 women who were referred for
colposcopic evaluation. Colposcopically directed brush cytology and
biopsy were performed for all patients with abnormal colposcopic
findings. A total of 40 samples were excluded due to unsatisfactory
report of brush cytology. Of the remaining 110 samples, 34 abnormal
pathologies were reported in biopsy evaluations, while only 9 abnor-
mal cytologies were reported in brush cytology specimens. Brush cytol-
ogy sensitivity and specificity were 26% and 97%, respectively. We
conclude that colposcopically directed brush cytology is not a safe
substitute for biopsy in the evaluation of cervical lesions.
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Cervical cancer is the second most common neoplastic
disease among women(1). An effective and convenient
cancer screening followed by early, appropriate treat-
ment could reduce cancer-associated death in women.
In colposcopically abnormal findings suspected to be
dysplastic, biopsy is the only test to confirm or rule
out premalignant or malignant lesions. Many patients
are reluctant to undergo the test because of biopsy
complications such as bleeding, abdominal pain, and
vaginal infection. Also, the preparation of samples needs
specific time, expertise, and facilities. Therefore, eco-
nomically biopsy is a costly test for both patients and
health systems. A study has shown that biopsy could
be safely substituted by brush cytology in pregnant
women(2). A good number of endocervical cells could
be obtained by endocervical brushing(3). In this study,
we evaluated the potential use of colposcopically di-
rected brush cytology instead of biopsy for detection
of dysplasia.
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Materials and methods
The study population consisted of 150 women referred
to the colposcopy center at Mirza Koochak Khan Hos-
pital from January 2000 to January 2001. The reasons
for reference to the center were abnormal Pap smear
test, abnormal appearance of cervix observed with the
naked eye, postcoital bleeding, or follow-up for previ-
ously diagnosed dysplastic lesion. Ethically, informed
consent, privacy, and confidentiality were observed
based on the Ethical Committee in the Tehran Univer-
sity of Medical Sciences, Iran. Before the screening
procedure, information about age, marriage status,
pregnancies, labors, abortions, live children, history of
smoking, vaginal discharge, and contraception method
were obtained. All examinations and biopsies were
done by one expert (Z.E.). For each sampling, the pa-
tient was placed in the lithotomy position and a specu-
lum was inserted into the vagina. If the patient had
not undergone Pap smear for the last 2 months, a Pap
smear was obtained. Then, a 3–5% acetic acid solution
was applied to the cervicovaginal surface to visualize
any evidence of dysplasia with the naked eye(4,5).
After concise visualization of squamocolumnar junc-
tion (transitional zone), total area of transformation zone
was carefully observed. In the case of observation of
any abnormal vessel, leukoplakia, or acetowhite le-
sion, a brush cytology specimen was collected from
that site, using a single Cytobrush (Medscand, Malmo¨,
Sweden). To expose a larger surface of Cytobrush
swab to the selected site, the Cytobrush was bent 45
(Fig. 1). Then, each specimen was obtained by scrap-
ing back and forth across the area several times. The
sample was spread onto a glass slide, which then was
placed in 95% ethanol fixative. Then, a cervical biopsy
was performed at the same area of lesion. All brush
cytology and biopsy samples were evaluated by one
expert pathologist (N.I-M.) and reported according to
the 2001 Bethesda System(6) and Modified Richart
Classification(7), respectively.
Based on the pathologic findings, the results were
divided into three subgroups: a) no change or some
reactive changes, namely atypical squamous cells of
undetermined significance; b) cervical intraepithelial
neoplasia (CIN) grade I in biopsy samples or low-grade
squamous intraepithelial lesion in brush samples; and
c) CIN-II and CIN-III or high-grade squamous intraepi-
thelial lesion.
Statistical evaluations included analyses of sensitivity
and specificity (with 95% confidence interval [CI95%])
and the kappa statistic using SPSS Software, Version 9.0.
Results
Of the 150 women who were screened, 150 sample
pairs of brush cytology and biopsy were prepared.
Forty samples were excluded from the study because
of inadequate sample size due to obscuring blood in
brush cytology samples, leaving 110 samples pairs for
analyses. Based on Bethesda System classification(6),
40 samples were unsatisfactory for evaluation because
more than 75% of smear surface was covered by blood,
and among observable cells, no abnormal cell was
seen. The high number of unsatisfactory slides might
be due to use of the conventional method for smear
preparation, as in this method removal of blood was
not possible.
Based on the demographic data, the patients were
between 20 and 66 years of age (38.5  9.4). Only 4.5%
of patients had never been pregnant. Seventy-three pa-
tients (66.4%) did not mention any history of cervical
dysplasia. Seventeen patients (15.5%) had unsatisfac-
tory colposcopy.
Figure 1. The straight cytobrush (the lower one) is bent about 45 (the upper one) to expose more brushing surface to the site of sampling.
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Table 1 compares the test results obtained by brush
and biopsy techniques. Among 110 biopsied samples,
32 showed low-grade CIN-I and 2 were identified as
high-grade CIN-II and CIN-III based on the Modified
Richart Classification(7). The directed brush cytology
demonstrated relatively poor agreement with the cor-
responding biopsy (j ¼ 0.29) as it detected both cases
of high-grade squamous intraepithelial lesion (CIN-II
and CIN-III), but only seven cases of low-grade squa-
mous intraepithelial lesion (CIN-I). Overall brush
cytology identified 9 of 34 biopsy-proved dysplasia,
therefore, the sensitivity of directed brush cytology
was 26% (CI95% ¼ 13.5–44.7), while its specificity was
97.4% (CI95% ¼ 90–99.5) with an accuracy rate of 75.5%.
Discussion
Cervical cancer screening in less-developed countries
is based on annual Pap smears. When Pap smears
show abnormal cervical cytology, the next step is bi-
opsy, which is usually a costly procedure that causes
discomfort for patients. In one study, Lieberman et al.
showed that in pregnant women brush cytology could
be used as a substitute for biopsy(2). The brush cytol-
ogy technique is much easier to perform than biopsy.
Also, there are fewer complications such as bleeding
and abdominal cramps.
In obtaining samples for cervical smears, brushing
is an efficient cell-collecting device(8–10). Also, endocer-
vical cytobrush sampling was proved to be a suitable
procedure in the detection of intraepithelial neoplastic
lesions(11). Also, it has been demonstrated that brush
cytology shows a safe adjunct to the colposcopic eval-
uation when endocervical curettage is not possi-
ble(3,12). Brush cytology has been used in the screening
procedures of some other neoplastic lesions such as
nasopharyngeal carcinoma, gastric malignancy, pan-
creas cancer, and lung tumors(13–16).
Based on the apparent usefulness of brush cytology
in the early diagnosis of CIN, we compared the test re-
sults of colposcopically directed brush cytology to that
of biopsy as the gold standard test. The brush cytology
confirmed 9 of 34 specimens with dysplasia proved in
biopsy (26% sensitivity). Brush cytology confirmed both
high-grade preneoplastic lesions, similar to that ob-
served by Lieberman et al. in their studies(2). This may
be due to the presence of more exfoliated abnormal
cells in the area of sampling as dysplastic cells tend to
detach from each other.
Overall, our results show that cytobrush is not a
safe substitute for biopsy. The sensitivity of brush
cytology (26%) is much lower than that (86%) of the
study by Lieberman et al.(2). This might be due to the
fact that they did their study on pregnant women,
while none of our patients were pregnant. In preg-
nancy, the cervical cellularity increases. This may
lead to better and easier sampling by brushing. Fur-
ther studies on larger patient populations may
show usefulness of brush cytology in evaluation of
cervical dysplasia. As we did not have the sample size
in mind when we planned the study, this study can be
considered a pilot study. Some confounding factors
might be ignored in the present work such as limita-
tion of the study to one specific group. Also, use of
thin-PREP instead of conventional smears may
improve the accuracy of our test result as several stud-
ies in recent years declare a significant improvement
in sensitivity of disease detection using thin-layer
preparations as compared to the conventional Pap
smears(17–20).
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